Limitations of the MTT Assay in Cell Viability Testing

被引:0
作者
Jaszczyszyn, Agata [1 ]
Gasiorowski, Kazimierz [1 ]
机构
[1] Silesian Piasts Univ Med, Dept Basic Med Sci, PL-51601 Wroclaw, Poland
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2008年 / 17卷 / 05期
关键词
MTT assay; PI exclusion-test; lymphocyte cultures; doxorubicin; fluphenazine;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. The MTT assay is widely recommended for examining the cytotoxic effect of xenobiotics, assessing proliferation rates, and analyzing cell activity. The aim of this study was to evaluate the usefulness of the MTT assay in examining human lymphocyte viability in own cell culture systems which contained fluphenazine (FPh), a suspected cancer chemopreventive agent, and doxorubicin (DOX), an anticancer drug, in cell culture medium. Material and Methods. Cell culture viability was estimated with two tests: the MTT assay and the propidium iodide (PI) exclusion assay. These results were compared using the standard ANOVA procedure. Results. The propidium iodide exclusion-test, a microscopic assay of cell culture viability, revealed an increase in dead cell number in cultures treated with DOX and an absence of viable cell changes in cultures treated with FPh in the range of the tested concentrations. The results obtained with the MTT reduction assay in the cultures gave the opposite results; the assay did not mirror the real viable cell number in these cultures. Statistical analysis demonstrated that the results obtained with the two assays differed significantly. Conclusions. This study shows that the MTT assay is not a feasible tool for determining cell viability in cultures in which DOX and FPh are used and possible sources of the limitations of the MTT assay are discussed (Adv Clin Exp Med 2008, 17, 5, 525-529).
引用
收藏
页码:525 / 529
页数:5
相关论文
共 18 条
[1]   The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction [J].
Belyanskaya, Larisa ;
Manser, Plus ;
Spohn, Philipp ;
Bruinink, Arle ;
Wick, Peter .
CARBON, 2007, 45 (13) :2643-2648
[2]   Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay [J].
Bruggisser, R ;
von Daeniken, K ;
Jundt, G ;
Schaffner, W ;
Tullberg-Reinert, H .
PLANTA MEDICA, 2002, 68 (05) :445-448
[3]  
Chakrabarti R, 2000, J CELL BIOCHEM, V80, P133
[4]   The mitochondrial uncoupler dicumarol disrupts the MTT assay [J].
Collier, AC ;
Pritsos, CA .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (02) :281-287
[5]  
DENGLER WA, 1995, ANTI-CANCER DRUG, V6, P1
[6]   RAPID COLORIMETRIC ASSAY FOR CELL-GROWTH AND SURVIVAL - MODIFICATIONS TO THE TETRAZOLIUM DYE PROCEDURE GIVING IMPROVED SENSITIVITY AND RELIABILITY [J].
DENIZOT, F ;
LANG, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 89 (02) :271-277
[7]  
Gasiorowski K, 2003, CELL MOL BIOL LETT, V8, P927
[8]   Antimutagenic activity of fluphenazine in short-term tests [J].
Gasiorowski, K ;
Brokos, B ;
Szyba, K ;
Leszek, J .
MUTAGENESIS, 2001, 16 (01) :31-38
[9]   Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity [J].
Gonzalez, RJ ;
Tarloff, JB .
TOXICOLOGY IN VITRO, 2001, 15 (03) :257-259
[10]  
HOFMAN FM, 1982, AM J CLIN PATHOL, V77, P710